S&P 500

5.827,04

-1,54%

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

TARS Tarsus Pharmaceuticals Inc

53,00

-2,24 (-4,06%)

11 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

November 13, 2024 Katherine Goodrich

Tarsus Pharmaceuticals (NASDAQ:TARS)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Tarsus Pharmaceuticals Charts.

Tarsus Pharmaceuticals (NASDAQ:TARS)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

News Tarsus Pharmaceuticals Inc

Form 8-K - Current report
Donnerstag 19 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Donnerstag 14 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Mittwoch 13 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Tarsus Reports Third Quarter and Year-to-Date 2024 Financial Results and Recent Business Achievements
Mittwoch 13 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Tarsus Welcomes Kate Goodrich, M.D., MHS, to its Board of Directors
Mittwoch 13 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 6 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Tarsus to Report Third Quarter 2024 Financial Results on Wednesday, November 13, 2024
Mittwoch 6 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Dienstag 5 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Tarsus Pharmaceuticals Inc News-Artikel

BOV

EXES11

Exes Fundo De Investimen...

BOV

TRNT11

Fdo Invest Imobiliario T...

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

TARS Tarsus Pharmaceuticals Inc

News Tarsus Pharmaceuticals Inc

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen

Trends

Toplisten

Marktdaten

News

Werkzeuge

Märkte

Entdecken

Hot Features

Follow Feed

Optionen-Flow

Watchlist

TARS Tarsus Pharmaceuticals Inc

News Tarsus Pharmaceuticals Inc

Kürzlich von Ihnen besucht

Unternehmen

Geschäft

Popular

App herunterladen